PreprintCited by 533Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsCholangiocarcinoma and Gallbladder Cancer Studies

The DOI matches its Crossref record; 394 of the 394 references it cites were found in a registry or an index.

Genetics and biology of pancreatic ductal adenocarcinoma

Open access

Ying, Haoqiang, Dey, Prasenjit, Yao, Wantong, Kimmelman, Alec C., Draetta, Giulio F., Maitra, Anirban, DePinho, Ronald A.·2016·Genes & Development

DOI 10.1101/gad.275776.115

Open this paper in CoChat — free account

Abstract

With 5-year survival rates remaining constant at 6% and rising incidences associated with an epidemic in obesity and metabolic syndrome, pancreatic ductal adenocarcinoma (PDAC) is on track to become the second most common cause of cancer-related deaths by 2030. The high mortality rate of PDAC stems primarily from the lack of early diagnosis and ineffective treatment for advanced tumors. During the past decade, the comprehensive atlas of genomic alterations, the prominence of specific pathways, the preclinical validation of such emerging targets, sophisticated preclinical model systems, and the molecular classification of PDAC into specific disease subtypes have all converged to illuminate drug discovery programs with clearer clinical path hypotheses. A deeper understanding of cancer cell biology, particularly altered cancer cell metabolism and impaired DNA repair processes, is providing novel therapeutic strategies that show strong preclinical activity. Elucidation of tumor biology principles, most notably a deeper understanding of the complexity of immune regulation in the tumor microenvironment, has provided an exciting framework to reawaken the immune system to attack PDAC cancer cells. While the long road of translation lies ahead, the path to meaningful clinical progress has never been clearer to improve PDAC patient survival.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.275776.115

Cites

394 of 394 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
The chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783

Show all 392 references

Research works printed but not linked: 1

Kloppel G . 2000. WHO classification of tumours. IARC Press, Lyon, France.

Sorted by citations

Items 201–300 of 533

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms
Chang, C., Liu, F., Militi, S., Hester, S. S., Nibhani, R., Deng, S., Dunford, J. E., Rendek, A., Soonawalla, Z. F., Fischer, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47680-z · Cited by 31
Engineering Cells for Cancer Therapy
Liu, P., & Hu, Q. (2024) · Accounts of Chemical Research · doi:10.1021/acs.accounts.4c00293 · Cited by 29
The cellular origins of cancer with particular reference to the gastrointestinal tract
Alison, M. R. (2020) · International Journal of Experimental Pathology · doi:10.1111/iep.12364 · Cited by 29
Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells
Stoica, A.-F., Chang, C., & Pauklin, S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.09.008 · Cited by 30
An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential
Guz, M., Jeleniewicz, W., & Cybulski, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031234 · Cited by 29
Palmitoyl transferase ZDHHC20 promotes pancreatic cancer metastasis
Tomić, G., Sheridan, C., Refermat, A. Y., Baggelaar, M. P., Sipthorp, J., Sudarshan, B., Ocasio, C. A., Suárez‐Bonnet, A., Priestnall, S. L., Herbert, E., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114224 · Cited by 31
Role of MTH1 in oxidative stress and therapeutic targeting of cancer
Taiyab, A., Ashraf, A., Sulaimani, M. N., Rathi, A., Shamsi, A., & Hassan, M. I. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103394 · Cited by 30
Role of Gene Therapy in Pancreatic Cancer—A Review
Sato‐Dahlman, M., Wirth, K. M., & Yamamoto, M. (2018) · Cancers · doi:10.3390/cancers10040103 · Cited by 28
ATG7 is a haploinsufficient repressor of tumor progression and promoter of metastasis
Long, J. S., Kania, E., McEwan, D. G., Barthet, V. J. A., Brucoli, M., Ladds, M. J. G. W., Nössing, C., & Ryan, K. M. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113465119 · Cited by 28
Preparation and in vitro assessment of wet-spun gemcitabine-loaded polymeric fibers: Towards localized drug delivery for the treatment of pancreatic cancer
Wade, S. J., Amanda, Z., Foroughi, J., Talebian, S., Aghmesheh, M., Moulton, S. E., & Vine, K. L. (2017) · Pancreatology · doi:10.1016/j.pan.2017.06.001 · Cited by 29
MCOLN1 Promotes Proliferation and Predicts Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma
Hu, Z., Yan, J., Cao, K.-Y., Yin, Z., Xin, W.-W., & Zhang, M. (2019) · Disease Markers · doi:10.1155/2019/9436047 · Cited by 27
Retracted
Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo
Han, X., Kuang, T., Ren, Y., Lu, Z., Liao, Q., & Chen, W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111605 · Cited by 27
Oncogenic KRAS promotes growth of lung cancer cells expressing SLC3A2-NRG1 fusion via ADAM17-mediated shedding of NRG1
Shin, D. H., Kim, S. H., Choi, M., Bae, Y., Han, C., Choi, B. K., Kim, S. S., & Han, J. (2021) · Oncogene · doi:10.1038/s41388-021-02097-6 · Cited by 28
The Heterocellular Emergence of Colorectal Cancer
Tape, C. J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2016.12.004 · Cited by 24
Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?
Ferreira, R. G., Narvaez, L. E. M., Espíndola, K. M. M., Rosario, A. C. R. S., Lima, W. G. N., & Monteiro, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.594917 · Cited by 12
Long Non-Coding RNAs in Epithelial-Mesenchymal Transition of Pancreatic Cancer
Takahashi, K., Taniue, K., Ono, Y., Fujiya, M., Mizukami, Y., & Okumura, T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.717890 · Cited by 26
A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts
Hoover, M. Y., Adamian, Y., Brown, M. J., Maawy, A. A., Chang, A., Lee, J., Gharibi, A., Katz, M. H. G., Fleming, J. B., Hoffman, R. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11809 · Cited by 25
Ductal metaplasia in pancreas
Li, S., & Xie, K. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188698 · Cited by 27
IL-39 acts as a friend to pancreatic cancer
Manning, A. A., Zhao, L., Zhu, Z., Xiao, H., Redington, C. G., Ding, V. A., Stewart-Hester, T., Bai, Q., Dunlap, J., Wakefield, M. R., et al. (2018) · Medical Oncology · doi:10.1007/s12032-018-1236-y · Cited by 25
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
O'Connor, C. A., Harrold, E. C., Lin, Y.-T., Walch, H. S., Gazzo, A. M., Ranganathan, M., Kane, S. R., Keane, F., Schoenfeld, J. D., Moss, D., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.3651 · Cited by 24
Research progress and design optimization of CAR‐T therapy for pancreatic ductal adenocarcinoma
Li, T., Li, H., Li, S., Xu, S., Zhang, W., Gao, H., Xu, H., Wu, C., Wang, W., Yu, X., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2430 · Cited by 25
Conformational Fluctuations in GTP-Bound K-Ras: A Metadynamics Perspective with Harmonic Linear Discriminant Analysis
Wang, X. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00844 · Cited by 23
The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold
Rubin, S. J. S., Sojwal, R. S., Gubatan, J. M. B., & Rogalla, S. (2022) · Cancers · doi:10.3390/cancers14174236 · Cited by 24
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets
Roberto, M., Arrivi, G., Civita, M. A. D., Barchiesi, G., Pilozzi, E., Marchetti, P., Santini, D., Mazzuca, F., & Tomao, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1154581 · Cited by 26
Proteomics-Driven Biomarkers in Pancreatic Cancer
Ramalhete, L., Vigia, E., Araújo, R., & Marques, H. P. (2023) · Proteomes · doi:10.3390/proteomes11030024 · Cited by 27
Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression
Xu, R., He, W., Tang, J., Guo, W., Zhuang, P., Wang, C., Fu, W.-M., & Zhang, J. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.026 · Cited by 24
A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients
Saha, G., Singh, R., Mandal, A., Das, S. K., Chattopadhyay, E., Panja, P., Roy, P., Sarkar, N. D., Gulati, S., Ghatak, S., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00183-1 · Cited by 23
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer
Ohkuma, R., Yada, E., Ishikawa, S., Komura, D., Kubota, Y., Hamada, K., Horiike, A., Ishiguro, T., Hirasawa, Y., Ariizumi, H., et al. (2020) · Oncology Reports · doi:10.3892/or.2020.7610 · Cited by 23
MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4
Liu, D., Jin, Y., Wu, J., Zhu, H., & Ye, D. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00814-y · Cited by 23
The Gut Microbiome and Pancreatic Cancer Development and Treatment
Attebury, H., & Daley, D. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000647 · Cited by 24
Challenging cancer targets for aptamer delivery
de Franciscis, V. (2017) · Biochimie · doi:10.1016/j.biochi.2017.09.014 · Cited by 23
Silver-Nanoparticle-Mediated Therapies in the Treatment of Pancreatic Cancer
Foulkes, R., Asgari, M. A., Curtis, A. D. M., & Hoskins, C. (2019) · ACS Applied Nano Materials · doi:10.1021/acsanm.9b00439 · Cited by 23
Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
Du, W., di Magliano, M. P., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682217 · Cited by 22
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Vitorakis, N., Gargalionis, A. N., Papavassiliou, K. A., Adamopoulos, C., & Papavassiliou, A. G. (2024) · Cancers · doi:10.3390/cancers16162876 · Cited by 25
Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
Hayashi, H., Uemura, N., Liu, Z., Matsumura, K., Sato, H., Shiraishi, Y., & Baba, H. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.700315 · Cited by 25
S-Nitrosylation at the intersection of metabolism and autophagy: Implications for cancer
Guil‐Luna, S., Sánchez-Montero, M. T., & Rodríguez‐Ariza, A. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189012 · Cited by 22
PDX1: A unique pancreatic master regulator constantly changes its functions during embryonic development and progression of pancreatic cancer
Vinogradova, T. V., & Sverdlov, E. D. (2017) · Biochemistry (Moscow) · doi:10.1134/s000629791708003x · Cited by 22
Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
Shen, Q., Yu, M., Jia, J.-K., Li, W., Tian, Y., & Xue, H. (2018) · Medical Science Monitor · doi:10.12659/msm.906313 · Cited by 22
Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
Rozengurt, E., & Eibl, G. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i15.1797 · Cited by 22
Listeria monocytogenes Cancer Vaccines: Bridging Innate and Adaptive Immunity
Morrow, Z. T., Powers, Z. M., & Sauer, J. (2019) · Current Clinical Microbiology Reports · doi:10.1007/s40588-019-00133-4 · Cited by 23
Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor
Langdon, C. G., Platt, J. T., Means, R. E., Iyidogan, P., Mamillapalli, R., Klein, M., Held, M. A., Lee, J. W., Koo, J. S., Hatzis, C., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0794 · Cited by 20
Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor
Ricciardiello, F., Bergamaschi, L., Vitto, H. D., Yang, G., Zhang, T., Palorini, R., & Chiaradonna, F. (2021) · Cells · doi:10.3390/cells10020431 · Cited by 21
Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis
Ferri-Borgogno, S., Barui, S., McGee, A. M., Griffiths, T., Singh, P. K., Piett, C. G., Ghosh, B., Bhattacharyya, S., Singhi, A., Pradhan, K., et al. (2020) · Cancers · doi:10.3390/cancers12092695 · Cited by 22
Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
Zhang, J., Tian, Y. Z., Mo, S. J., & Fu, X. F. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s341332 · Cited by 19
Recent Advancements of Nanotechnology-Based Strategies for Overcoming Tumor Microenvironment Hypoxia
Wu, J., Song, J., Yin, X., Tang, J., Zhang, J., Wang, X., Ji, Y., Zhao, Y., Chen, D., Sheng, J., et al. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705145 · Cited by 20
SREBP-Dependent Regulation of Lipid Homeostasis Is Required for Progression and Growth of Pancreatic Ductal Adenocarcinoma
Ishida, C. T., Myers, S. L., Shao, W., McGuire, M. R., Liu, C., Kubota, C. S., Ewachiw, T. E., Mukhopadhyay, D., Ke, S., Wang, H., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0120 · Cited by 19
Proteome-Wide Protein Expression Profiling Across Five Pancreatic Cell Lines
Paulo, J. A., Mancias, J. D., & Gygi, S. P. (2017) · Pancreas · doi:10.1097/mpa.0000000000000800 · Cited by 19
Engineering of biomaterials for tumor modeling
Choi, S. R., Yang, Y., Huang, K., Kong, H., Flick, M. J., & Han, B. (2020) · Materials Today Advances · doi:10.1016/j.mtadv.2020.100117 · Cited by 20
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
Makler, A., Narayanan, R., & Asghar, W. (2022) · Biosensors · doi:10.3390/bios12100831 · Cited by 19
Mind the (guidance) signals! Translational relevance of semaphorins, plexins, and neuropilins in pancreatic cancer
Fard, D., Giraudo, E., & Tamagnone, L. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.07.009 · Cited by 22
Smad4 regulates TGF-β1-mediated hedgehog activation to promote epithelial-to-mesenchymal transition in pancreatic cancer cells by suppressing Gli1 activity
Guo, H., Hu, Z., Yang, X., Yuan, Z., Wang, M., Chen, C., Xie, L., Gao, Y., Li, W., Bai, Y., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.03.010 · Cited by 21
Hippo Signaling Pathway in Pancreas Development
Wu, Y., Aegerter, P., NIPPER, M. J., Ramjit, L. R., Liu, J., & Wang, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.663906 · Cited by 23
Potent pro-apoptotic combination therapy is highly effective in a broad range of cancers
Montinaro, A., Zubiaur, I. A., Saggau, J., Kretz, A.-L., Ferreira, R. M. M., Hassan, O., Kitzig, E. F., Müller, I., El-Bahrawy, M. A., von Karstedt, S., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00869-x · Cited by 20
ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer
Xu, G., Shen, J., Xu, Y., Wang, W., & Ni, C. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9500 · Cited by 19
Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner
Gamradt, P., Thierry, K., Masmoudi, M., Wu, Z., Hernández‐Vargas, H., Bachy, S., Antonio, T., Savas, B., Hussain, Z., Tomasini, R., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad405 · Cited by 18
Hallmarks of pancreatic cancer: spotlight on TAM receptors
Vázquez-Bellón, N., Martínez‐Bosch, N., de Frutos, P. G., & Navarro, P. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105278 · Cited by 20
BAG3‐positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma
Yuan, Y., Jiang, J., Wang, J., Sun, J. T., Li, C. R., Liu, B.-Q., Yan, J. Y., Meng, X., & Wang, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14352 · Cited by 18
The biology of pancreatic cancer morphology
McDonald, O. G. (2021) · Pathology · doi:10.1016/j.pathol.2021.09.012 · Cited by 20
Recent advances in understanding pancreatic cancer
Stott, M. C., Oldfield, L. S., Hale, J. J., Costello, E., & Halloran, C. M. (2022) · Faculty Reviews · doi:10.12703/r/11-9 · Cited by 19
Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival
Urbanova, M., Cihova, M., Buociková, V., Slopovský, J., Dubovan, P., Pinďák, D., Tomáš, M., García‐Bermejo, L., Rodríguez-Garrote, M., Earl, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115179 · Cited by 19
Chemoprevention and Treatment of Pancreatic Cancer: Update and Review of the Literature
Benzel, J., & Fendrich, V. (2018) · Digestion · doi:10.1159/000485741 · Cited by 17
Mst1/2 kinases restrain transformation in a novel transgenic model of Ras driven non-small cell lung cancer
Singh, K., Pruski, M. A., Polireddy, K., Jones, N. C., Chen, Q., Yao, J., Dar, W. A., McAllister, F. M., Ju, C., Eltzschig, H. K., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1031-z · Cited by 18
Self-citation
Pancreatic and duodenal homeobox-1 in pancreatic ductal adenocarcinoma and diabetes mellitus
Tang, Z., Chu, Y., Tan, Y., Li, J., & Gao, S. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000628 · Cited by 19
The unfolded protein response: An emerging therapeutic target for pancreatitis and pancreatic ductal adenocarcinoma
Borrello, M. T., Martin, M. B., & Pin, C. L. (2021) · Pancreatology · doi:10.1016/j.pan.2021.10.007 · Cited by 18
Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer
Xiong, G., Pan, S., Jin, J., Wang, X., He, R., Peng, F., Xu, L., Wang, M., Zheng, J., Zhu, F., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.765216 · Cited by 18
Application of deep generative model for design of Pyrrolo[2,3-d] pyrimidine derivatives as new selective TANK binding kinase 1 (TBK1) inhibitors
Song, S., Tang, H., Ran, T., Fěng, F., Tong, L., Chen, H., Xie, H., & Lu, X. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115034 · Cited by 17
Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
Marin, A. M., Batista, M., de Azevedo, A. L. K., Gomig, T. H. B., Brant, R. S. C., Chammas, R. J., Uno, M., Araújo, D. D., Zanette, D. L., & Aoki, M. N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612604 · Cited by 17
Transcriptome Reprogramming of CD11b+ Bone Marrow Cells by Pancreatic Cancer Extracellular Vesicles
Maia, J., Otake, A. H., Poças, J., Carvalho, A. S., Beck, H. C., Magalhães, A., Matthiesen, R., Moraes, M. C. S., & Costa‐Silva, B. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.592518 · Cited by 17
Epigenetic Mechanisms beyond Tumour–Stroma Crosstalk
Gagliano, T., & Brancolini, C. (2021) · Cancers · doi:10.3390/cancers13040914 · Cited by 19
Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma
Wang, D., Liu, K., Yang, Y., Wang, T., Rao, Q., Guo, W., & Zhang, Z. (2019) · Future Oncology · doi:10.2217/fon-2019-0684 · Cited by 18
Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty
Akalın, A. A., Dedekargınoğlu, B., Choi, S. R., Han, B., & Özçelikkale, A. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03298-8 · Cited by 16
Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development
Chaves-Almagro, C., Auriau, J., Dortignac, A., Clerc, P., Lulka, H., Deleruyelle, S., Projetti, F., Nakhlé, J., Francès, A., Berta, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810600 · Cited by 16
Pancreatic Cancer and Detection Methods
Ungkulpasvich, U., Hatakeyama, H., Hirotsu, T., & di Luccio, E. (2023) · Biomedicines · doi:10.3390/biomedicines11092557 · Cited by 15
Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
Thakur, G., Kumar, R., Kim, S.-B., Lee, S.-Y., Lee, S., & Rho, G. (2021) · Biomedicines · doi:10.3390/biomedicines9020178 · Cited by 16
KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism
Muyinda, I. J., Park, J. G., Jang, E., & Yoo, B. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105070 · Cited by 16
Simultaneous Inhibition of MEK and Hh Signaling Reduces Pancreatic Cancer Metastasis
Gu, D., Lin, H., Zhang, X., Fan, Q., Chen, S., Shahda, S., Liu, Y., Sun, J., & Xie, J. (2018) · Cancers · doi:10.3390/cancers10110403 · Cited by 16
Challenges and Opportunities in Modeling Pancreatic CancerPreprint
Feigin, M. E., & Tuveson, D. A. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.031104 · Cited by 16
The Diagnostic Accuracy of Mutant KRAS Detection from Pancreatic Secretions for the Diagnosis of Pancreatic Cancer: A Meta-Analysis
Patel, N. M., Petrinic, T., Silva, M., Soonawalla, Z. F., Reddy, S., & Gordon-Weeks, A. N. (2020) · Cancers · doi:10.3390/cancers12092353 · Cited by 15
Co-dependencies in the tumor immune microenvironment
Chen, P., & Dey, P. (2022) · Oncogene · doi:10.1038/s41388-022-02406-7 · Cited by 15
Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells
Xu, J., Lina, Z., Du, X., Qi, Z., Chen, S., Zhang, J., Cao, X., & Xia, J. (2023) · Metabolites · doi:10.3390/metabo13111132 · Cited by 15
Hope on the Horizon: A Revolution in KRAS Inhibition Is Creating a New Treatment Paradigm for Patients with Pancreatic Cancer
Aguirre, A. J., Stanger, B. Z., & Maitra, A. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1926 · Cited by 15
Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics
Cintas, C., Douché, T., Therville, N., Arcucci, S., Ramos‐Delgado, F., Basset, C., Thibault, B., & Guillermet‐Guibert, J. (2018) · Cancers · doi:10.3390/cancers10060174 · Cited by 16
MT1-MMP as a PET Imaging Biomarker for Pancreas Cancer Management
Morcillo, M. Á., de Lucas, Á. G., Oteo, M., Romero, E., Magro, N., Ibanez-Moragues, M., Martínez, A., Garaulet, G., Arroyo, A. G., Lopez-Casas, P. P., et al. (2018) · Contrast Media & Molecular Imaging · doi:10.1155/2018/8382148 · Cited by 15
Prognostic Value of Drug Targets Predicted Using Deep Bioinformatic Analysis of m6A-Associated lncRNA-Based Pancreatic Cancer Model Characteristics and Its Tumour Microenvironment
Cao, P., Liu, L., Li, Z.-H., Cao, F., & Liu, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.853471 · Cited by 15
Pancreatic HIF2α Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm
Schofield, H. K., Tandon, M., Park, M.-J., Halbrook, C. J., Ramakrishnan, S. K., Kim, E. C., Shi, J., Omary, M. B., Shah, Y. M., Esni, F., et al. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.10.008 · Cited by 15
Two Birds with One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts
Ling, J., & Chiao, P. J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1460 · Cited by 15
Prognostic value of KRAS subtype in patients with PDAC undergoing radical resection
Dai, M., Jahanzaib, R., Liao, Y., Yao, F., Li, J., Teng, X., Chen, K., & Cheng, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1074538 · Cited by 15
Tumor Microenvironment Role in Pancreatic Cancer Stem Cells
Galindo-Vega, A., Maldonado, V., Mitre-Aguilar, I. B., & Meléndez-Zajgla, J. (2023) · Cells · doi:10.3390/cells12121560 · Cited by 14
Glutamine analogs for pancreatic cancer therapy
Kalaany, N. Y. (2024) · Nature Cancer · doi:10.1038/s43018-023-00678-w · Cited by 13
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development
Schneider, A. T., Koppe, C., Crouchet, É., Papargyriou, A., Singer, M. T., Büttner, V., Keysberg, L. S., Szydlowska, M., Jühling, F., Moehlin, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56493-7 · Cited by 14
The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
Ponath, V., Frech, M., Bittermann, M., Khayer, R. A., Neubauer, A., Brendel, C., & von Strandmann, E. P. (2020) · Cancers · doi:10.3390/cancers12102857 · Cited by 12
Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
Parrasia, S., Zoratti, M., Szabó, I., & Biasutto, L. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000326 · Cited by 14
LSL-KrasG12D; LSL-Trp53R172H/+; Ink4flox/+; Ptf1/p48-Cre mice are an applicable model for locally invasive and metastatic pancreatic cancer
Ma, L.-X., & Saiyin, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176844 · Cited by 13
FAM84B, amplified in pancreatic ductal adenocarcinoma, promotes tumorigenesis through the Wnt/β-catenin pathway
Zhang, X., Xu, J., Yan, R., Zhang, Y., Hu, Z., Fu, H., You, Q., Cai, Q., & Yang, D. (2020) · Aging · doi:10.18632/aging.103044 · Cited by 14
Inflammation, microbiota, and pancreatic cancer
Chen, X., Sun, F., Wang, X., Feng, X., Aref, A. R., Tian, Y., Ashrafizadeh, M., & Wu, D. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03673-6 · Cited by 15
A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer
Calheiros, J., Silva, R., Barbosa, F., Morais, J., Moura, S. R., Almeida, S., Fiorini, E., Mulhovo, S., Aguiar, T. Q., Wang, T., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03389-5 · Cited by 13
Heparanase Inhibition by Pixatimod (PG545): Basic Aspects and Future Perspectives
Hammond, E., & Dredge, K. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_22 · Cited by 13
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 13
MicroRNA‑23b‑3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF‑κB signaling pathways
Zhang, Y., Chen, D., Zhang, G., Wu, X., Zhou, L.-Y., Lin, Y., Ding, J., An, F., & Zhan, Q. (2020) · Oncology Letters · doi:10.3892/ol.2020.12021 · Cited by 13
The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?
Fleury, E. D. F. C., Nimir, C., & D’Alessandro, G. S. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s294166 · Cited by 13

Authors: Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A.
Affiliations: The University of Texas MD Anderson Cancer Center (US)
Dana-Farber Cancer Institute (US)
ORCID: Ying, Haoqiang
Dey, Prasenjit
Yao, Wantong
Kimmelman, Alec C.
Draetta, Giulio F.
Maitra, Anirban
DePinho, Ronald A.
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2016-02-15
Volume: 30
Issue: 4
Pages: 355-385
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.275776.115
OpenAlex: W4295846302
Cited by: 527
References: 392
Citations by year: 2026: 20 · 2025: 33 · 2024: 44 · 2023: 68 · 2022: 56 · 2021: 75 · 2020: 57 · 2019: 48 · 2018: 51 · 2017: 59 · 2016: 16
Type: posted content
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc
Locations: Genes & Development (publishedVersion, cc-by-nc)
HighWire Press Open Archive (submittedVersion)
Funders: Sheikh Ahmed Center for Pancreatic Cancer Research
Pancreatic Cancer Moon Shot at the University of Texas MD Anderson Cancer Center
University of Texas Star Award (W81XWH-14-1-0429)
Department of Defense (U01DK108328, U01CA196403)
Odyssey Fellowship (Anne Eastland Spears Fellowship in GI Cancer Research)
University of Texas MD Anderson Cancer Center (RSG-13-298-01-TBG)
American Cancer Society (R01GM095567, R01CA157490, R01CA188048)
National Institutes of Health (14-90-25-DRAE, P01CA117969)
American Association for Cancer Research (W81XWH-11-1-0418)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
Keywords: pancreatic ductal adenocarcinoma, cancer genomics, molecular classification, cancer metabolism, DNA repair, tumor microenvironment, cancer immunotherapy, drug discovery, obesity, metabolic syndrome, preclinical models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genetics and biology of pancreatic ductal adenocarcinoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks